If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
181.20    -2.40 (-1.31%)
Bid:
181.60
Ask:
182.40
Spread: 0.80 (0.441%)
Market Cap: £440.69m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

24 May 2018 07:00

RNS Number : 0930P
Sabre Insurance Group PLC
24 May 2018
 

24 May 2018

 

SABRE INSURANCE GROUP PLC

Trading Update

Sabre Insurance Group plc (the "Group", or "Sabre"), one of the UK's leading private motor insurance underwriters, today publishes a trading update ahead of its AGM to be held later this morning.

Summary

· As set out in our 2017 full year results, in common with the rest of the motor market, we experienced competitive pricing in the last few weeks of 2017 which continued into the first two months of 2018 resulting in a modest reduction in premium income relative to the same period in 2017

 

· Pricing action was taken in early March to reflect the improving claims trends, specifically lower whiplash claims frequency, which has resulted in gross written premium ("GWP") returning to approximately 2017 levels on a weekly run-rate basis with no deterioration in our expected underwriting margins. Given this GWP for the year to 30 April 2018 is down year on year by around 5% at £69.8m(1) (2017: £73.1m(1))

 

· The Group continues to deliver leading underwriting performance supported by positive claims experience in the early months of 2018, and therefore reiterates the full year guidance for the 2018 underwriting performance reflecting a combined ratio slightly better than our long-term target of mid-70%'s

 

· A solvency ratio of over 188%(1) at the end of March exceeds our 140% - 160% target corridor, with organic capital being generated on a monthly basis

Geoff Carter, CEO, commented:

"Profitability of business written remains our key priority, with gross written premium and growth being an output rather than a target. Whilst we saw a reduction in premium income in the first two months of the year relative to the equivalent period last year, we took pricing action in early March which was supported by the emerging claims data. Following this action, volumes of new business on a weekly run-rate basis have returned to similar levels as the equivalent period in 2017 without any deterioration in expected underwriting margins. As such we remain confident in performing slightly better than our mid-70%'s combined ratio target for 2018, given our claims experience to date.

The motor market remains in a choppy state as competitors react to the early signs of changing claims patterns. Much uncertainty remains on the end state of these changes, not least around the critical Ogden discount rate which may impact overall claim costs and reinsurance pricing, making it difficult to predict the outcome for pricing and volumes for the remainder of the year and beyond. However, the market appears to have reacted rationally to reflect real-world changes in the cost of claims. Since we undertook our pricing action earlier this year we have seen no significant change in the pricing environment in our sector and, as such, currently expect our 2018 GWP position to be broadly in line with 2017. Assuming no changes to the current environment, we would expect modest GWP growth in 2019, without deterioration from our current underwriting margins.

In summary, we are encouraged by the start to the year. We remain absolutely committed to our core principle of underwriting discipline over GWP growth. We believe this will deliver a strong underwriting performance, and allow us to continue strengthening our capital position which will support the delivery of an attractive dividend, in line with our policy (stated at the time of the IPO) of paying out surplus capital by way of ordinary and special dividends."

(1) Numerical information not subject to audit

Media enquiries

Tulchan Communications LLP

James Macey White, Roger Tejwani & David Ison

020 7353 4200

sabre@tulchangroup.com

Investor enquiries

Sabre Insurance Group plc

Geoff Carter & Adam Westwood

0330 024 4696

adam.westwood@sabre.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFMDFASEFI
Date   Source Headline
30th Jun 20201:33 pmRNSDirector/PDMR Shareholding
11th Jun 20201:59 pmRNSDirector/PDMR Shareholding
10th Jun 20209:57 amRNSDirector/PDMR Shareholding - Correction
4th Jun 20209:49 amRNSDirector/PDMR Shareholding
29th May 20203:39 pmRNSDirector/PDMR Shareholding
29th May 202012:37 pmRNSDirector/PDMR Shareholding
21st May 202012:17 pmRNSResult of AGM
21st May 20207:00 amRNSTrading Statement
13th May 20202:24 pmRNSDirector/PDMR Shareholding
12th May 202011:54 amRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSHolding(s) in Company
1st May 202011:58 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSNotice of AGM
24th Apr 202011:44 amRNSHolding(s) in Company
23rd Apr 20202:08 pmRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSHolding(s) in Company
20th Apr 20201:58 pmRNSDirector/PDMR Shareholding
16th Apr 20202:57 pmRNSDirector/PDMR Shareholding
7th Apr 20203:45 pmRNSDirector/PDMR Shareholding
7th Apr 202012:02 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSFinal Results
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202012:23 pmRNSNotification of Results Announcement Date
24th Mar 20207:00 amRNSDelay of Full Year results announcement
20th Mar 20204:48 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 202012:07 pmRNSSecond Price Monitoring Extn
18th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 202010:45 amRNSDirector/PDMR Shareholding
9th Mar 202012:07 pmRNSSecond Price Monitoring Extn
9th Mar 202012:02 pmRNSPrice Monitoring Extension
28th Feb 202010:14 amRNSDirector Declaration
11th Feb 20203:07 pmRNSDirector/PDMR Shareholding
13th Jan 20201:53 pmRNSDirector/PDMR Shareholding
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
11th Dec 201911:41 amRNSDirector/PDMR Shareholding
22nd Nov 20198:50 amRNSHolding(s) in Company
12th Nov 20192:35 pmRNSDirector/PDMR Shareholding
6th Nov 20191:57 pmRNSHolding(s) in Company
22nd Oct 20194:55 pmRNSHolding(s) in Company
22nd Oct 20194:52 pmRNSHolding(s) in Company
15th Oct 201910:03 amRNSDirector/PDMR Shareholding
11th Oct 20193:12 pmRNSDirector/PDMR Shareholding
11th Oct 201910:58 amRNSDirector/PDMR Shareholding
10th Oct 20197:00 amRNSTrading Update
20th Sep 201911:14 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.